| Hemodynamic diagnostics of epicardial coronary stenoses: in-vitro experimental and computational study1Department of Mechanical, Industrial and Nuclear Engineering, 601B Rhodes Hall, University of Cincinnati, Clifton Avenue, Cincinnati, OH, USA 2Department of Internal Med-Cardiology, MSB, University of Cincinnati, Cincinnati, OH, USA 3Jet Propulsion Laboratory, California Institute of Technology, Pasadena, CA, USA 4Department of Biomedical Engineering, 598 Rhodes Hall, PO Box 210072, Cincinnati OH, 45221 0072, USA
BioMedical Engineering OnLine 2008, 7:24doi:10.1186/1475-925X-7-24 The electronic version of this article is the complete one and can be found online at: http://www.biomedical-engineering-online.com/content/7/1/24
©
2008 Banerjee et al; licensee BioMed Central Ltd. AbstractBackgroundThe severity of epicardial coronary stenosis can be assessed by invasive measurements of trans-stenotic pressure drop and flow. A pressure or flow sensor-tipped guidewire inserted across the coronary stenosis causes an overestimation in true trans-stenotic pressure drop and reduction in coronary flow. This may mask the true severity of coronary stenosis. In order to unmask the true severity of epicardial stenosis, we evaluate a diagnostic parameter, which is obtained from fundamental fluid dynamics principles. This experimental and numerical study focuses on the characterization of the diagnostic parameter, pressure drop coefficient, and also evaluates the pressure recovery downstream of stenoses. MethodsThree models of coronary stenosis namely, moderate, intermediate and severe stenosis, were manufactured and tested in the in-vitro set-up simulating the epicardial coronary network. The trans-stenotic pressure drop and flow distal to stenosis models were measured by non-invasive method, using external pressure and flow sensors, and by invasive method, following guidewire insertion across the stenosis. The viscous and momentum-change components of the pressure drop for various flow rates were evaluated from quadratic relation between pressure drop and flow. Finally, the pressure drop coefficient (CDPe) was calculated as the ratio of pressure drop and distal dynamic pressure. The pressure recovery factor (η) was calculated as the ratio of pressure recovery coefficient and the area blockage. ResultsThe mean pressure drop-flow characteristics before and during guidewire insertion indicated that increasing stenosis causes a shift in dominance from viscous pressure to momentum forces. However, for intermediate (~80%) area stenosis, which is between moderate (~65%) and severe (~90%) area stenoses, both losses were similar in magnitude. Therefore, guidewire insertion plays a critical role in evaluating the hemodynamic severity of coronary stenosis. More importantly, mean CDPe increased (17 ± 3.3 to 287 ± 52, n = 3, p < 0.01) and mean η decreased (0.54 ± 0.04 to 0.37 ± 0.05, p < 0.01) from moderate to severe stenosis during guidewire insertion. ConclusionThe wide range of CDPe is not affected that much by the presence of guidewire. CDPe can be used in clinical practice to evaluate the true severity of coronary stenosis due to its significant difference between values measured at moderate and severe stenoses. BackgroundIn current clinical practice, the ischemic severity of epicardial coronary stenosis can be detected by functional and anatomical measurements. The anatomical or geometric measurements, performed by imaging methods (e.g., contrast angiography, angioscopy and intravascular ultrasound), may not reveal the true severity of coronary stenosis and may lead to inappropriate clinical decisions [1]. On the other hand, functional or hemodynamic measurements of mean pressure drop across the stenosis and distal coronary flow prove to be more useful for the long term success of balloon angioplasty with or without stent placement procedure [2]. Hence, the development of simple and effective clinical diagnostic methods utilizing these functional measurements has attracted the interest of many researchers. For this purpose, the intravascular clinical procedure is performed before the angioplasty by surgically placing a 2–2.3 mm diameter guide-catheter up to the coronary ostium. The 0.35 mm diameter pressure or Doppler flow sensor-tipped guidewire is advanced through this guide-catheter and placed across the stenosed coronary artery to measure distal pressure or flow [3]. Using this invasive pressure and flow measurement, various diagnostic parameters have been developed in current clinical practice e.g. coronary flow reserve (CFR: the ratio of hyperemic flow to the basal flow) [4], trans-stenotic pressure drop [5], fractional flow reserve (FFR: the ratio of distal recovered pressure to the aortic pressure at hyperemia) [6]. Uncertainties in pressure-flow diagnosticsTo distinguish epicardial stenosis severity from microvascular dysfunction, simultaneous measurements [7] of the coronary flow and pressure have been recently recommended [8,9]. For this purpose, both pressure and flow sensors are simultaneously inserted into the coronary vessel. However, the insertion of guidewires across the stenosis causes a "tight fit" in the lumen of the stenosed artery and is associated with additional flow reduction and an increase in mean pressure drop [2,5] that may result in an incorrect overestimation [10,11] of hemodynamic parameters [12] and may lead to improper selection of therapeutic procedures [13,14]. Possible risks and resulting consequences to the patients because of the uncertainties in pressure drop and flow measurements due to the size and number of guidewires inside the diseased vessel were recently reported. In earlier clinical study, clinicians observed that the diastolic pressure drop measured by a balloon catheter (1.98 mm size) was 34% more than that measured by a single guidewire (0.45 mm size) [14], typically used in present clinical settings. In a study of 65 patients, Verberne et al [11] reported a 25% increase in hyperemic pressure drop and a 20% reduction in hyperaemic flow with the use of two guidewires (separate pressure- and flow sensor- tips on different guidewires; a procedure not commonly used) instead of a newly developed single guidewire having both pressure and flow sensors on its tip. Further data analysis indicated 30%, 128% and 325% increase in the misdiagnosis (false positive cases) of the true ischemic severity of coronary stenosis due to wrong measurements of CFR, FFR and hyperemic stenosis resistance (hSRv: the ratio of hyperemic pressure drop and distal blood flow velocity), respectively [11]. The uncertainty in deciding the limiting values of CFR, FFR and pressure drop measured by different sizes of guidewires, has been experimentally [15] and numerically evaluated and discussed in detail in our previous studies [16,17]. We hypothesized that the hemodynamic parameter consisting of simultaneous measurements of pressure-flow integrated with anatomical details can overcome the disadvantages of conventional diagnostic parameters. Recently, our group has developed an alternative diagnostic parameter: Lesion flow coefficient (LFC: ratio of non-dimensional pressure drop at very high flow rate and at patho-physiological hyperemic flow rate) [17] to determine the true severity of epicardial coronary stenosis. Accordingly, in this study, we sought to investigate the behaviour of the non-dimensional hemodynamic or functional diagnostic parameter, pressure drop coefficient (CDPe), over a wide range of coronary flows simulated in an in-vitro experimental set up. The CDPe utilizes simultaneous pressure-flow measurement across the stenosis, while evaluating the downstream pressure recovery factor (η) that includes simultaneous pressure-flow measurement and anatomical details. The specific aims of this study are: 1) to compare the pressure drop-flow relation for pulsatile flow in the presence and absence of single guidewire, 2) To evaluate the behaviour of hemodynamic parameter, CDPe while evaluating η for different degrees of stenoses under variable pressure-flow scenarios. MethodsFormulationHemodynamic diagnostic parameter: pressure drop coefficient (CDPe)We define the CDPe to be the ratio of mean trans-stenotic pressure drop, where, ρ is blood density; Pressure recovery factor (η)Applying Bernoulli's equation to the stenotic geometry, pressure recovery coefficient (CPR) can be defined as the ratio of distal pressure recovery ( where, where CPR∞ is expressed as We define Δpr = pr - pmand α is the ratio of the flow cross-sectional area of the distal vessel, Ar, to the minimum vessel area at the site of stenosis, Am, prior to guidewire insertion. α = um/ur = Ar/Am = Ae/Am(4) where, A is the cross-sectional area, subscript 'r' represents the distal vessel; 'm' represents the vessel at the site of stenosis with minimum flow area; 'e' represents the proximal healthy vessel. For simplicity, it is assumed that Ar = Ae i.e. proximal and distal vessel diameters are the same. Similarly, we define αi to be the ratio of the flow cross-sectional area of the distal vessel (Ar-Ai) to the minimum vessel area at the site of stenosis (Am-Ai), during guidewire insertion. αi = (Ar - Ai)/(Am - Ai) = (Ae - Ai)/(Am - Ai)(5) where, subscript 'i' represents the guidewire. Further, the % occlusion of the vessel or % area stenosis is defined as follows: Percentage area stenosis = (Ae - Am)/(Ae)(6) Here, the pressure recovery factor (η) measures the ability of distal vessel to recover the pressure downstream to the stenosis [19] and have wide application in nozzle flow fluid dynamics. Experimental methodSimultaneously measured pressure and flow data for each stenosis test sections were compared with corresponding numerical calculations. The Coronary Stenosis Test SectionsWe created three model test sections to simulate different severity of epicardial focal coronary stenosis. These test sections are manufactured with optical grade Lexan material for following three severity conditions: moderate, intermediate and severe stenosis, having % area occlusion of 65%, 80% and 89%, respectively. Epicardial focal coronary stenosis consists of three distinct sections, converging or constricting, throat, and diverging section as shown in Fig. 1A, B[13,20]. The above manufactured test sections are as per the characteristic dimensions reported by Wilson et al. ([13], Table 1). To measure the axial pressure and time averaged pressure recovery (
Table 1. Dimensions for three stenotic test sections. All dimensions are measured with ImageJ software® Experimental SetupThe diastole-dominated coronary arterial flow waveform was generated by compliance-resistance method as explained in our previous in-vitro study [15]. The schematic diagram of experimental set up is shown in Fig. 2. The basic pulsatile flow waveform (T = 0.8 sec,
For reference steady flow experiments, gravity induced constant flow was supplied through the stenotic test section. The steady flow (Q) was increased from basal to hyperemic flow in four steps, while trans-stenotic pressure and flow were measured simultaneously. During each step of flow increment, the guidewire was inserted across the stenotic test section to measure trans-stenotic pressure and flow. Pressure and Flow MeasurementsThe axial pressure was measured by a DSA3207 digital sensor array (Scanivalve corp., WA) with 12 ms time interval. The pulsatile flow was measured with an in-line Doppler flow sensor (Transonic Inc., NY) with a time interval of 1 ms. Simultaneous pressure-flow values were measured for the following two conditions: 1) Before guidewire insertion: This method can be considered as "non-invasive or patho-physiological" measurements, since pressure was measured without guidewire insertion across the stenotic models. 2) During guidewire insertion: This method can be considered as "invasive" measurements, since pressure was measured after guidewire insertion across the stenotic model. The guidewire was connected to the ComboMap system (Volcano Therapeutic, CA) for continuous pressure recording during its insertion across the stenotic models. Blood Analog Fluid (BAF)The experiments were performed with a fluid exhibiting the shear thinning, non-Newtonian viscous property of blood. The BAF was prepared by mixing 65% water, 35% glycerine, and 0.02% Xanthum gum (by weight) [23]. The viscosity was measured by concentric cylinder viscometer (DV-II+ PRO Digital Viscometer, Brookfield, MA). The experimental data, showing shear-thinning behaviour of BAF, were fitted to Carreau model (Eq. in Fig 5), where the Carreau coefficients are as follows: zero shear rate viscosity, μ0 = 55 cP, infinite shear rate viscosity, μ∞ = 3.39 cP, time constant, λ = 9.56 s, and power index, n = 0.2. The comparison of BAF viscosity and real blood viscosity [24] is provided in Fig. 5. The density of BAF was measured as 1.05 g/cm3. The comparison of results between BAF and blood viscosities is discussed in Additional file 1. Additional File 1. Appendix – I: Effect of blood viscosity. This is the appendix for the manuscript explaining the effect of blood analog fluid viscosity on the trans-stenotic pressure drop ( Format: DOC Size: 30KB Download file This file can be viewed with: Microsoft Word Viewer
Numerical methodGeometryThe numerical calculations were performed based on the dimensions of in-vitro stenotic test sections as provided in Table 1. Two numerical models were generated for each stenotic test section; namely, before and during guidewire insertion. Mesh diagrams 'during' and 'before' guidewire insertion are shown in Fig. 6A and Fig. 6B. It is assumed that: (a) the arterial wall has a smooth, rigid and round concentric shape; (b) the stenosis geometry remains unchanged during basal and hyperemic flow due to failure of the flow-dependent dilation mechanisms in atherosclerotic coronary arteries; and (c) the rigid arterial wall has insignificant effect of pressure pulsation on its dimensions.
Boundary and Initial ConditionsThe 'no slip' boundary condition, ui = 0, was specified on the arterial wall and on the guidewire wall (in case of guidewire inserted conditions). A stress free boundary condition (σi = 0) was applied at the flow outlet. The symmetric boundary condition (ur = 0) was applied at the central axis in the case of 'before' guidewire insertion. The coronary flow waveform, Q(t), used in the computational analyses, was obtained from the corresponding in-vitro experimental data. The spatially averaged velocity along the vessel cross-section, before guidewire insertion and during guidewire insertion for annular flow Because of long entry length, the spatial velocity profiles at any instance of time adjusted to a profile that is consistent for non-Newtonian BAF fluid. The temporal mean pressures were calculated along the arterial wall to find the mean pressure drop, Solution StrategyThe unsteady problem was solved by finite element method utilizing the Galerkin scheme (FIDAP, ANSYS, Inc., NH). The pressure was discredited by mixed formulation and approximated as discontinuous across the element boundaries for this incompressible flow problem. The 2nd order implicit trapezoidal time integration scheme was used to control local truncation error. A successive substitution type of fully coupled iterative solver was used to obtain the solution at each time step of this non-linear time-dependent problem. This method solves the linearized system of governing equations by direct Gaussian elimination approach. The convergence criteria for the velocity and residual vector were tightened to a value of 0.01% which is two orders of magnitude lower than the recommended value [27]. In order to optimize the convergence time at each time step, a relaxation factor was used (0.5). To achieve smooth converged results, a relatively small value of streamline upwinding (a value less than 0.45) that adds numerical diffusion along the flow direction was used to calculate primary flow variables (u). For these analyses, a Compaq Linux machine with dual processor (2.4 GHz, 1 GB RAM, 80 GB hard disk) was utilized so that CPU time for each time step was ~1.5 s. Mesh refinement studyA series of meshes were created, with each one 20% higher in density than the previous one, in order to check the overall convergence accuracy of the numerical calculations [25-27]. When the improvement with the refined mesh was less than 1% in velocity vectors, wall shear stress, and pressure, the numerical calculation was considered to be converged. For pulsatile flow calculations, the convergence is not only dependent on the mesh resolution but also on the selection of the time step. Depending on the velocity pulse shape and stenosis geometry, the calculation time steps varied between 1 × 10-4 to 1 × 10-5 sec. These calculations were started from a time where the velocities were near zero in order to make the stiffness matrix well-balanced and stable. Considering the refinements in time-steps, and appropriate starting point of numerical calculations, one may not need much finer mesh for an unsteady calculation [25-27]. ResultsTrans-stenotic mean axial pressure dropThe experimentally measured and numerically calculated temporal mean axial pressure data were analyzed to determine the overall mean trans-stenotic pressure drop ( Moderate (65% area) stenosisFigure 7A shows the trans-stenotic mean axial pressure as a function of axial distance before guidewire insertion. The values of overall pressure drop (
Table 2. Mean Pressure drop and mean pressure recovery values before and during guidewire insertion Intermediate (80% area) stenosisBefore guidewire insertion (Fig. 8A), sudden pressure drop in the converging and throat region was observed with increased overall pressure drop as compared with moderate stenosis. The
Severe (89% area) stenosisBefore guidewire insertion, the overall pressure drop (
This study also suggests that the tip of the guidewire sensor should be positioned at sufficient distance distal to the stenosis. The pressure sensor tip should be positioned after the pressure recovery in order to avoid inaccuracy in distal pressure measurement. From axial pressure drop plots, shown in Figs. 7, 8 and 9, it is evident that the pressure tip should be at least 14 mm distal to the stenosis. Mean pressure drop and flow relationThe time averaged transient pressure drop-flow (
Table 3. Viscous (A) and momentum-change (B) coefficients; Pulsatile flow values are obtained from Figs 7A, B, and 7C For all stenotic models, the guidewire insertion increased the trans-stenotic pressure drop. The mean pressure drop for moderate stenosis (65% area stenosis) was governed by the viscous component, In addition, comparison of coefficients 'A' and 'B' for reference steady flow (not shown in the figure; shown in Table 3) and pulsatile flow showed that the pulsatile flow increased momentum-change effects significantly. For a selected mean flow rate, pressure drop for steady flow was lower than the time-averaged pulsatile flow cases. The comparison of steady and pulsatile flow coefficients shows that pulsatile flow increased Overall pressure drop coefficient (CDPe)The CDPe, a non-dimensional quantity, represents the fluid flow resistance added by any arterial conduit having both momentum-change- and viscous- related pressure losses. The coronary stenosis adds resistance to flow by blocking more lumen area and its severity ranges from moderate stenosis offering negligible blood flow resistance to the severe stenosis contributing considerable blood flow resistance. Figure 11 shows mean CDPe vs. Ree characteristic for each stenosis and flow condition before and during guidewire insertion. The CDPe was primarily dependent on stenosis geometry, shape of flow pulse, presence of guidewire and flow rate. The mean CDPe increased from 17 ± 3.3 for moderate stenosis to 287 ± 52 for severe stenosis (n = 3, p < 0.01 using unpaired t-test). For a given stenosis, values of CDPe: decreased with increase in Ree; increased after guidewire insertion; and are higher for pulsatile flow than those for steady flow cases.
Before guidewire insertion, from basal to hyperemic flow, CDPe decreased from 215 to 184 for severe stenosis and from 17 to 12 for moderate stenosis. Similarly, during guidewire insertion, CDPe changed from 372 to 247 for severe stenosis and from 22 to15 for moderate stenosis. The statistically significant difference in the range of CDPe values between moderate and severe stenosis can be used in the clinical practice in diagnosing the severity of stenosis. Figure 12 shows FFR-CDPe correlation showing a linear variation. The CDPe increased by a factor of 15 from moderate to severe stenosis model. This wide range of CDPe can be used to delineate the severity of coronary stenosis. Unlike FFR, CDPe is not limited between small range; therefore a better and much accurate cut-off value can be established for CDPe after human clinical trials. The linear correlation indicates CDPe could be a viable diagnostic parameter under clinical setting.
Pressure recovery factor (η)Pressure recovery, downstream of the stenosis, can be quantified by the pressure recovery factor (η). For given flow rate, as stenotic severity increases from moderate to intermediate, the CPR increases, signifying increased pressure recovery, while approaching CPR8. As a result, η could also increase to a limiting value of unity. Similarly, for a particular stenosis, as flow increases, η increases due to increase in CPR. Table 2 compares the η values, calculated before and during guidewire insertion. From basal to hyperemic flow, during guidewire insertion, η increased from 0.11 to 0.45 for moderate stenosis and from 0.36 to 0.42 for intermediate stenosis. However, it decreased from 0.46 to 0.31 for severe stenosis. Similarly, before guidewire insertion, η increased from 0.48 to 0.59 for moderate stenosis, remained nearly constant (0.47 to 0.48) for intermediate stenosis and reduced from 0.47 to 0.36 for severe stenosis. This indicates that the guidewire insertion reduces the ability of the diverging section to recover the downstream pressure. In future, the CPR and η values can be obtained by guidewire pressure pullback profile in conjunction with the area measurement by diagnostic imaging techniques (e.g. IVUS, angiograph) in clinical settings. DiscussionThe present study examines the pressure drop-flow relation for the range of epicardial coronary stenoses with quantification of The large difference between pressure drop values for the same mean flow implies that the contribution of viscous and momentum-change related pressure drops are different for steady and pulsatile flows. The pulsatile flows, having different Depending upon blood disorder, the effect of blood viscosity on diagnostic parameters should be analyzed since it may vary from patient to patient. The blood viscosity may affect the diagnostic procedure for intermediate and moderate stenosis as pressure drop for these geometries are dominated by viscous losses. In contrast, for the severe stenosis cases only momentum-change effects are significant and thus, blood viscosity may not have significant effect on diagnostic parameters. A new diagnostic parameter 'lesion flow coefficient' (LFC; see Additional file 2) was introduced to assess the severity of epicardial stenosis [15,17]. LFC is the ratio of square root of CDP8 (a limiting value of pressure drop coefficient at very high flow where viscous losses can be neglected over momentum-change losses) and square root of CDPm (pressure drop coefficient evaluated at the site of constriction at hyperemic flow where viscous and momentum-change pressure losses are equally important). As the flow increases, the CDPm approaches CDP8, leading to an LFC value of unity. The relation between CDPm, CDPe, CDP8 and LFC are summarized in Additional file 2. CDP∞ can be expressed as (1-1/α)2 where, α is area ratio term obtained from equation 5 [17]. Thus, LFC is a function of flow rate, the severity of stenosis, guidewire size and the pulse shape. The nature of viscous- and momentum change-related pressure losses for CDPe will help in understanding the characteristic of the LFC. The detailed axial pressure drop profiles for each stenosis severity obtained from this study provide additional insights for determining viscous- and momentum change-related pressure losses. Additional File 2. Appendix – II: Relation between cardiovascular diagonostic parameters. This is the appendix for the manuscript explaining the relation between cardiovascular diagonostic parameters: CDPe, CDPm and LFC. Format: DOC Size: 34KB Download file This file can be viewed with: Microsoft Word Viewer A wide range of CDPe reveals that it can itself be used as a diagnostic index and thus, it has its own clinical importance. Since calculation of CDPe requires simultaneous pressure and flow measurement, it may be used to detect epicardial stenosis under presence of microvascular disease. The wide and non-overlapping range of CDPe, e.g. 14–22 for moderate stenosis, 87–132 for intermediate stenosis and 251–375 for severe stenosis may be useful for the estimation of severity of coronary stenosis. This in-vitro data will be helpful to design future pre-clinical and clinical trials. The distal pressure recovery and η signifies the influence of pressure recovery, distal vascular-bed pressure and position of epicardial stenosis in relation to the location of guidewire on diagnostic parameters. The pull-back image obtained by IVUS catheter and pressure pull-back profile obtained by pressure guidewire can be recorded in a catheterization laboratory and may be combined to determine distal pressure recovery and η. Physiological limitations to the distal coronary pressure-flow dataThe
Table 4. Mean Hemodynamic end points in terms of CFR and Table 5. Estimated hyperemic diagnostic parameters during guidewire insertion Eccentricity effectMaximum difference between the experimentally measured and numerically calculated
ConclusionThe guidewire insertion caused reduction in hyperemic flow and increased the trans-stenotic pressure drop, that affected the viscous- and momentum change-related pressure losses. The pressure drop coefficient (CDPe) increased by a factor of 15 from moderate to severe stenosis model and thus diminishes the overall effect of guidewire flow obstruction and related misdiagnosis during invasive functional measurements. This wide range of CDPe can be used to delineate the severity of coronary stenosis. Unlike FFR, CDPe is not limited between small range; therefore a better and much accurate cut-off value can be established after human clinical trials. The pressure recovery factor (η) quantifies the recovered distal vascular-bed pressure downstream of the stenosis. The geometrical details of coronary stenosis included in the expression for η combines the functional and anatomical information. CDPe and η need to be further evaluated for pre-clinical studies in order to distinguish between epicardial and microvascular dysfunction. List of Abbreviations usedA – flow cross-sectional area, d – diameter of the vessel at specified section, l – length of vessel at specified section, p – vessel pressure, Δp – pressure drop (pressure gradient in clinical literature): Δpc + Δpm – Δpr, Δpr – distal pressure recovery: Subscripts a – aorta, c – converging section of the stenosis, e – proximal section to the stenosis, h – hyperemic condition for flow and pressure, i – guidewire, m – t – minimum temporal value, m – throat section, o – mean diameter, p – t – peak temporal value, r – distal section/diverging region of the stenosis. Superscripts ~ – time average (mean) quantity over cardiac cycle, - – spatial average quantity across the vessel Competing interestsThe authors declare that they have no competing interests. Authors' contributionsKDA carried out the stenotic models and experimental setup design, trans-stenotic pressure-flow measurements, numerical calculations and participated in the sequence alignment and drafted initial versions of the manuscript under supervision of RKB. SFK provided the important clinical pressure-flow measurement information. TAH and MAE provided clinical insights of the guidewire diagnostics and formatted the background section. LHB provided technical insights into this research during experimental setup, stenosis model design, experimental and numerical data analysis and critically revised the draft. All authors read and approved the final manuscript. AcknowledgementsThis work is supported by American Heart Association: National-Scientific Development Grant (#0335270N). Authors would like to thank Dr. Bernard J. Dardzinski of Cincinnati Children's hospital, for providing the MicroCT facility used for the accurate dimensional measurements of the test sections. We are also grateful to Tristate cutting tool Inc, for manufacturing the stenosis test models to highest precision level. Authors want to acknowledge the help of Dr. Abhijit Sinha Roy during the experimental setup and test section design. We are thankful to all members of the Bio-Fluid, Heat, and Mass Transport Lab (Bio-FHM), Mr. Doug Hurd of Mechanical engineering machine shop at University of Cincinnati for their assistance during these in-vitro experiments. References
Have something to say? Post a comment on this article! |




on Google Scholar







author email
corresponding author email


















Figure 1.
Figure 2.
Figure 3.
Figure 4.
Figure 5.
Figure 6.




Figure 7.
: Numerical results.
Figure 8.
Figure 9.
Figure 10.
Figure 11.
Figure 12.






Figure 13.
Figure 14.
Figure 15.
